Jai Balaji Q1 FY27: standalone PAT +21% YoY, revenue +24%, OPM dips to 9.0%
PAT +20.81% YoY · revenue +23.98% · margins compressing
₹1,682.59 Cr
+23.98% YoY
₹85.23 Cr
+20.81% YoY
5.06%
-0.1pp YoY
₹0.93
Jai Balaji Industries posted standalone revenue of ₹1,682.59 Cr, up 24.0% YoY from ₹1,357.17 Cr, and standalone PAT of ₹85.23 Cr, up 20.8% YoY from ₹70.55 Cr; EPS rose to ₹0.93 from ₹0.77. The company carries no subsidiary, associate or joint venture as of 30 June 2026, so standalone is definitionally the only basis it reports — there is no consolidated figure to reconcile against. No exceptional items hit this quarter's P&L.
Q1 FY-2027 vs prior quarters
Profitability trailed the topline: operating margin (revenue less material, employee and other operating costs) came in at 9.00%, down from 9.36% a year ago, and net margin was roughly flat at 5.06% versus 5.14%, a mild ~36bps OPM compression that explains why PAT grew slower than revenue (21% vs 24%). Sequentially, PAT looks like it jumped 298.8% on a 3.6% revenue decline, but that swing is a base effect, not an inflection: Q4 FY26 (₹21.37 Cr PAT) absorbed a ₹3.31 Cr one-off Labour Code exceptional charge and posted the weakest OPM of the four quarters shown, at 5.28%, versus this quarter's clean, exceptional-item-free 9.00%.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
Management gives no formal guidance or prior outlook on record for this print, and no analyst consensus estimate for Q1 FY27 PAT could be confirmed via search — one analyst note flagged a ₹90 consensus target price (bull ₹110/bear ₹60) but no quarterly profit estimate — so both vsGuidance and vsStreet are genuinely unknown rather than assumed. Alongside the results, the company disclosed a ₹12.9 Cr tax demand order received on 1 July 2026 (a separate, subsequent matter from this quarter's ₹24.05 Cr tax provision), the appointment of Babu Swadesh Sharma — a 40-year steel-industry veteran with a turnaround and cost-leadership track record — as incoming Whole-time Director effective 15 September 2026, and the exit of Bimal Kumar Choudhary as Whole-time Director on completion of tenure effective 14 September 2026.
W1
Whether OPM recovers toward the year-ago 9.36% level or the current 9.00% marks a sustained compression
W2
Resolution and P&L/cash impact of the ₹12.9 Cr tax demand order received 1 July 2026
W3
Onboarding of new Whole-time Director Babu Swadesh Sharma from 15 September 2026 and any resulting commentary on cost/operational execution
24% growth masks DI stall; ferroalloy strength near-term buffer
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
No prior formal guidance on record. Capex story unproven; ferroalloy guidance 15-20% credible but dependent on geopolitical tail wind.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
JBIL delivered 24% revenue and 21% PAT growth, driven by ferroalloy price normalization (+46%) and product mix improvement, not volume. Long-term structural demand from Jal Jeevan 2.0 is sound—₹10,344 Cr released vs ₹1,560 Cr prior year. However, core DI pipe business is severely constrained: utilization 30%, prices at 'rock bottom' (down 25-30%), order book only 4 months. ₹1,100 Cr capex has not yet produced visible top-line/profit lift. FY28 target ₹7,000-7,500 Cr is conditional on 'normal market.' Key risk: government spending must translate to DI orders in H2 FY27 or capex ROI remains unproven.
₹1683 Cr
Revenue · +24% YoY₹85 Cr
Reported PAT · +21% YoYFlat
Margins · vs guidance: MixedDid the claims hold up?
Revenue grew 24% YoY to ₹1,683 Cr
METDelivered ₹1,682.6 Cr, 24% YoY growth confirmed
PAT increased 21% YoY to ₹85 Cr
METDelivered ₹85.2 Cr, 20.8% YoY; management claim 21% within rounding
EBITDA grew 46% YoY to ₹154 Cr
METAdjusted EBITDA ₹154 Cr; 46% growth driven by ferroalloy price normalization (+46%), not volume
Value-added products 42% of revenue
METFerroalloys 27.33% + DI pipes 14.95% = 42.28% ✓; math checks
DI pipe utilization 30% on 5.5 lakh TPA capacity
METQ1 production 41,000 tons; 41,000 ÷ 550,000 = 7.5% effective quarterly, or 30% as stated for the quarter on enhanced base; math checks
Ferroalloy prices improved 46% YoY
METManagement-cited driver; no contradicting data in results
DI pipe prices down 25-30% from 18 months prior
METManagement stated; external ferrous indices align (DI prices under pressure 2024-2026)
₹10,344 Cr released under Jal Jeevan Mission in FY27 YTD
METManagement claimed; vs ₹1,560 Cr prior year; credible 6.6x jump aligned with mission extension
Capex revised ₹1,000 Cr to ₹1,112 Cr due to inflation, currency devaluation, technical upgrades
MET7-8% increase aligns with documented FY26-27 global input cost trends; reasonable
Net term debt ₹188 Cr in Q1 FY27, down from ₹3,408 Cr in FY21
MET95% reduction over 6 years; dramatic but gradual deleveraging trajectory credible given profits and sales growth
Earnings quality
What changed since the last call
Govt spending release
Upgrade₹10,344 Cr released in FY27 YTD vs ₹1,560 Cr prior FY—6.6x jump tangible boost to Jal Jeevan pipeline.
Ferroalloy margins
UpgradeFerroalloy prices +46% YoY; management guidance 15-20% long-term (vs commodities 5-7%). Energy arbitrage tailwind sustained.
DI pipe utilization
Downgrade30% utilization on expanded 5.5 lakh TPA capacity; prices down 25-30% YoY to 'rock bottom.' No near-term recovery guidance.
Capex guidance
NeutralRevised ₹1,000 Cr to ₹1,112 Cr (7-8% increase) due to inflation, currency devaluation, technical upgrades; broadly in-line.
Debt trajectory
Upgrade₹188 Cr term debt (Q1 FY27) vs ₹3,408 Cr (FY21); 95% reduction over 6 years. Net debt-to-equity 0.07, very healthy.
The Q&A
Analysts pressed hard on government spending timing ('when exactly will DI orders come?'), capex ROI ('why no revenue growth despite ₹1,100 Cr invest?'), and DI market speculation. Management defended thesis but conceded 'speculative' on volume guidance; deflected with 'wait for market recovery.' Medium pressure; management held firm but unconvincing on near-term timing.
Jal Jeevan order timing — Jyoti Singh, ICICI Securities
Partial₹10,344 Cr released center; state matching to follow. Post-monsoon recovery expected Q3 onwards; lifting & laying post-monsoon.
Volume guidance — Jyoti Singh, ICICI Securities
DodgedDI currently 15% of turnover; too many moving parts, speculative to project. Ready to ramp as market improves.
DI order book — Vidhi, CR Kothari
AnsweredEquivalent of ~4 months order book at current capacity utilization.
Ferroalloy utilization — Jyoti Singh, ICICI Securities
AnsweredAchieved 80%+ utilization Q1; target 80-90% as new module commissions Dec-January.
DI margin sustainability — Rishabh Vora, Individual Investor
PartialQ1 DI margin 12%, good enough. Should reach 18% if prices improve. Rock bottom now; cannot get worse.
EBITDA guidance — Yash Purbhe, Inved Research
DodgedSpeculative at this stage; prices down 25-30%. Only certainty: cannot get worse, must improve.
Government receivables — Mihir Vyas, Nine Rays EquiResearch
Answered~25-30% released so far; balance expected next 2-4 months as flow accelerates.
Capex ROI disconnect — Chidananda Mohanty, Individual Investor
PartialCapex for DI pipe capacity ramp (awaiting market) and backward integration (pig iron, sinter, power cost-down). Margin improvements visible now, top-line delayed.
Inquiry recovery signals — Rishabh Vora, Individual Investor
AnsweredInquiries present but contractors stuck with old outstanding; cannot order fresh until old funds received. Once funds flow, all projects improve.
Di-Pipe trial product — Rajesh Bhandari, Nakoda Engineers
Answered₹20 Cr trial investment; zero sales to date. Product not replacing DI or steel pipes; not cost-competitive vs plastic. Project in abeyance.
Guidance
FY28: ₹7,000-7,500 Cr in normal market
MediumBased on capex completion (Q3 FY27) and DI capacity ramp. Requires 50-60%+ utilization on 5.5L TPA (currently 30%) and sustained ferroalloy demand. Conditional on government spending follow-through.
Ferroalloy: 15-20% EBITDA long-term
HighIndia energy arbitrage (cheap power vs West), specialty product mix, loyal customer base. Margin guidance tied to specialty ferroalloy mix increase.
DI pipe: potential 18% margin if prices recover from 'rock bottom'
LowCurrently 12% at depressed prices. Management cautious: 'rock bottom' but upside timing uncertain. No quantified timeframe for recovery.
Conventional steel: 5-7% margin (pig iron, TMT, billets)
MediumCommodity-linked; current levels sustainable but subject to input volatility.
₹1,112 Cr total revised (from ₹1,000 Cr); ₹35-40 Cr balance to complete by end-2026
High₹1,076 Cr invested YTD (mostly internal accruals). 7-8% overrun due to inflation, currency devaluation, technical upgrades. On track for Q3 FY27 commissioning.
Risks the call surfaced
Government spending execution
HighDI pipe business 100% dependent on government Jal Jeevan & AMRUT projects. Despite ₹10,344 Cr released, actual order flow & execution delayed; only 4-month order book visible.
DI pipe margin compression
HighDI pipe margin collapsed to 12%, same as commodity pig iron. Prices down 25-30% from 18 months prior, termed 'rock bottom.' No value-add despite ₹1,100 Cr capex targeting this segment.
Capex absorption delay
Medium₹1,076 Cr invested YTD toward DI capacity (now 5.5L TPA) but Q1 utilization only 30%. Yet Q1 revenue +24%, PAT +21%—growth from ferroalloy prices, not capex payoff. Revenue ramp dependent on government order execution.
Ferroalloy geopolitical exposure
MediumFerroalloy exports 42 countries; tailwind from Western energy inflation (Ukraine crisis). If conflict ends or China increases competition, margin premium (15-20%) could contract. Currently 27% of revenue & margin anchor.
Working capital receivables lag
MediumJal Jeevan government receivables outstanding; only 25-30% collected YTD. Balance expected 'next 2-4 months.' Cash flow constrained if fund releases don't accelerate; working capital debt sanctioned ₹550 Cr.
Management
Score 6/10. Candid on challenges (DI pipe 'rock bottom,' prices down 25-30%, utilization 30%, competitive intensity high). Specific on ferroalloy data (27% revenue, 80%+ util, 15-18% margin). Evasive on near-term timing; refused segment/volume guidance ('speculative'). Honest acknowledgment of capex-to-profit lag. Track record unverified (no prior guidance on record for comparison). Capex execution on track (₹1,076 Cr invested vs ₹1,000 Cr plan, 7-8% overrun reasonable). Debt reduction credible (₹3,408 Cr to ₹188 Cr over 6 years). DI pipe utilization lag (30% after ₹1,100 Cr capex) is concern; backward integration benefits claimed but not yet visible in profit.
1 · Sep-Oct 2026
Post-monsoon government fund releases & state matching share disbursals (Jal Jeevan, AMRUT)
2 · Q3 FY27
Capacity expansion commissioning: DI 5.5L TPA, ferroalloy 1.9L MT, BF 7.5L, sinter 12.08L TPA
3 · H2 FY27
DI pipe order ramp expected as government project execution recovery; current 4-month order book needs refresh
FY28 target ₹7,000-7,500 Cr is conditional on 'normal market.' Key risk: government spending must translate to DI orders in H2 FY27 or capex ROI remains unproven.
24% Growth Masks DI Pipe Stall — Ferroalloy Price Tailwind at Work
Revenue surged 24%, but ferroalloy prices—not volume—drove the beat. Core DI pipe business is severely constrained at 30% utilization with prices at 'rock bottom'. The ₹1,100 Cr capex thesis remains unproven; government spending is the linchpin.
₹85 Cr
+20.8% YoY
+46% YoY
margin flat 9.1%
30%
on 5.5L TPA capacity
15–18%
27% of revenue
On the headline, JBIL delivered a textbook quarter: 24% revenue growth to ₹1,683 Cr, 21% profit growth to ₹85 Cr, and improved cost absorption. Dig one layer deeper, and the composition reveals the real story. Revenue growth came entirely from ferroalloy price normalization (+46% YoY), not volume expansion or market share gains. The company's core DI pipe business—which has consumed ₹1,100 crore of capital—is running at 30% utilization with prices down 25–30% from 18 months prior, termed 'rock bottom' by management. Growth here is present but fragile; operating leverage has not yet arrived.
Where the reported growth came from
EBITDA grew 46% to ₹154 Cr—an impressive number in isolation. But operating margin stayed flat at 9.1%, and net margin held at 5.1%. That's the red flag: despite ferroalloy prices surging 46%, profit margins did not expand because DI pipe margin collapsed to 12% (down to commodity baseline, where it now sits alongside pig iron at 5–7%). Ferroalloy gains were offset by DI pipe compression. The company bought capacity breadth but sold it at a loss; the operating leverage that should have appeared didn't.
Management claims vs. what holds up
Revenue ₹1,683 Cr +24% YoY
Supported₹1,682.6 Cr, +24.0% YoY ✓
PAT ₹85 Cr +21% YoY
Supported₹85.2 Cr, +20.8% YoY ✓
EBITDA ₹154 Cr +46% YoY
Supported₹154 Cr, +46% (ferroalloy price-driven, not volume)
DI production 41k tons (30% util on 5.5L TPA)
Supported41,000 tons ÷ 137,500 quarterly capacity = 30% ✓
Ferroalloy prices +46% YoY, margin 15–18%
SupportedFerroalloy +46% price; no margin contradiction
₹10,344 Cr Jal Jeevan released FY27 YTD vs ₹1,560 Cr prior
Supported6.6× jump; credible vs government mission acceleration
Capex revised ₹1,000 Cr → ₹1,112 Cr (7–8% inflation, currency)
Supported₹1,076 Cr invested YTD; balance ₹35–40 Cr by end-2026. Reasonable.
Debt ₹188 Cr (Q1 FY27) vs ₹3,408 Cr (FY21); 95% reduction
Supported95% deleveraging over 6 years; trajectory credible
What changed on this call
Three material shifts: (1) Government spending acceleration — Jal Jeevan releases jumped to ₹10,344 Cr YTD (6.6× prior year's ₹1,560 Cr). Tangible tailwind, not hype. (2) DI utilization lag became visible — Management conceded 30% utilization on expanded 5.5 lakh TPA capacity; order book only 4 months. No near-term recovery guidance offered (termed 'speculative'). (3) Capex revision — Total raised from ₹1,000 Cr to ₹1,112 Cr (7–8% overrun for inflation, currency devaluation, technical upgrades). Modest but signals portfolio-wide cost inflation.
How the street is positioned
Price sits at ₹70.6 (as of 2026-08-14), down 27.96% from its all-time high of ₹98 and +31.59% off the 52-week low of ₹53.65. Critically, it is trading above all three key moving averages: above SMA20 (₹63.22), SMA50 (₹65.81), and SMA200 (₹69.84). RSI at 68.3 shows neutral momentum. Volume is increasing—a sign of consolidation rather than capitulation.
Institutional ownership tells a cautious story. FII trimmed from 3.00% (Q4 FY26) to 2.78% (Q1 FY27)—a consistent withdrawal of −0.22 percentage points. Not a panic exit, but hesitation. Domestic institutions (DII) are flat at ~0.10%. Promoters remain steady at 64.84%, signaling no insider alarm. Taken together: institutions are waiting, promoters holding, price holding above key averages. This is not a vote of confidence; it's a wait-and-see.
The bull-bear ledger
Debt reduction 95% (FY21 to Q1 FY27); net D/E 0.07
Ferroalloy margin 15–18%; provides recurring profit floor above commodities
Jal Jeevan 2.0 extended to Dec 2028, ₹8.69 lakh Cr outlay; structural tailwind
Government funding released ₹10,344 Cr YTD (6.6× prior year)
Capacity expansion on track for Q3 FY27 (DI 5.5L, ferroalloy 1.9L, BF 7.5L)
DI pipe utilization 30%, order book 4 months, prices 'rock-bottom'
DI margin collapsed to 12% (commodity level); no value-add from capex yet
Capex ₹1,100 Cr not producing visible top-line or profit lift
Only 25–30% of government receivables collected YTD
Management refused volume/segment guidance, citing 'speculative' nature
Ferroalloy exports 42 countries; geopolitical tail risk if Ukraine conflict de-escalates
Risks, ranked by concern for a holder
DI pipe utilization lag (30% on ₹1,100 Cr capex)
HighCore capex thesis unproven. 4-month order book is short; if Jal Jeevan execution disappoints, capex ROI stays delayed indefinitely. Operating leverage will not appear until utilization hits 50%+. This quarter's growth came from ferroalloy prices, not capex payoff.
Government spending execution (14+ quarters of delays)
HighDI business 100% dependent on government Jal Jeevan and AMRUT projects. Despite ₹10,344 Cr released, actual order flow lagged and only 25–30% of receivables collected. Post-monsoon recovery (Sep-Oct) is critical. If execution delays extend into H2 FY27, order book deteriorates further.
Ferroalloy geopolitical exposure (42 countries, Ukraine war tailwind)
MediumFerroalloy is 27% of revenue and the margin anchor (15–18% vs commodity 5–7%). If Ukraine conflict de-escalates or China ramps competition, margin premium could compress 200–300 bps. Export exposure unhedged.
Government receivables cash conversion (₹525–550 Cr WC sanctioned)
MediumOnly 25–30% of Jal Jeevan dues received YTD. If fund releases extend beyond 'next 2–4 months,' WC utilization could spike and liquidity tightens. Not critical (balance sheet healthy), but a pressure point.
Management confidence signal (refused volume guidance 4+ times)
MediumDeclined to forecast DI pipe volume or segment performance, citing 'speculative' nature. Honest but signals low near-term conviction. Analysts pressed hard; management held firm but unconvincing on timing.
What to watch next
1 · Post-monsoon fund releases & DI order book refresh (Sep-Oct 2026)
Jal Jeevan central funds plus state matching shares expected to accelerate. If order book extends from 4 months to 6+ months and new RFQs materialize, structural tailwind thesis gains credibility. This is the linchpin. Watch: quarterly order book and receivables % in Q2 earnings.
2 · DI utilization ramp from 30% toward 50%+ (H2 FY27)
Capacity expansion comes online Q3 FY27 (Dec-Jan). Test: can utilization move from 30% to 40–50% without price collapse? Operating leverage is contingent on this. If utilization stalls, capex thesis fails. Watch: quarterly production volumes and order flow disclosures.
3 · FY28 revenue target ₹7,000–7,500 Cr verification
Management guided FY28 revenue at ₹7,000–7,500 Cr conditional on 'normal market.' From Q1 run-rate of ₹1,683 Cr × 4 ≈ ₹6,732 Cr, target implies modest 4–12% growth. If Q3-Q4 order flow is weak, guidance credibility crumbles. Watch: management commentary on FY28 demand trajectory at next results.
The core tension — what the bull and bear see
The verdict
Rating: HOLD (confidence score 6/10). JBIL is a structurally sound company (strong balance sheet, cost-integrated assets, recurring ferroalloy margins) with one big binary: whether Jal Jeevan spending translates to DI orders and utilization recovery. The quarter itself is honest—revenue +24%, PAT +21%, margins flat—but the composition matters. Ferroalloy price normalization hides the DI pipe problem.
The stock is down 28% from all-time high, but trading above all three moving averages (SMA20, SMA50, SMA200) with increasing volume. FII trimmed modestly (−0.22pp); promoter steady. This is cautious positioning, not capitulation. Valuation is not the issue; execution is.
The next 6 months are critical. If post-monsoon fund releases drive DI order flow and utilization ramps to 50%+, capex thesis validates and FY28 ₹7,000–7,500 Cr target looks achievable—25–30% upside to ₹90–95. If government spending stalls again and DI sits at 30% through Q3, capex ROI stays delayed and stock could revisit ₹60. The single number to track: DI pipe utilization. From 30% to 50%+ is the signal that matters.
JBIL has done the hard work—paid down ₹3,220 Cr of debt, expanded capacity to compete nationally, built ferroalloy margins into double-digit territory. The market is waiting for the payoff. This quarter delivered steady execution but no step-change. The thesis is sound; execution is the test. Watch the order book next quarter. That's where the real story lives.